Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.47
- Piotroski Score 7.00
- Grade Buy
- Symbol (TARO)
- Company Taro Pharmaceutical Industries Ltd.
- Price $42.98
- Changes Percentage (0.01%)
- Change $0.01
- Day Low $42.94
- Day High $42.98
- Year High $45.76
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.
- Last Earnings 11/05/2018
- Ex-Dividend for 5/16 Dividend 12/10/2018
- Dividend Payable 12/28/2018
- Today N/A
- Next Earnings (Estimated) 07/24/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $1.43
- Trailing P/E Ratio 29.91
- Forward P/E Ratio 29.91
- P/E Growth 29.91
- Net Income $53.87 M
Income Statement
Quarterly
Annual
Latest News of TARO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Bills QB Josh Allen cleared to play, while DB Taron Johnson ruled out against Miami on Thursday
Buffalo Bills coach Sean McDermott ruled out cornerback Taron Johnson from playing against Miami, while quarterback Josh Allen is cleared to play despite injuring his non-throwing hand. Johnson's inju...
By AP NEWS | 3 weeks ago -
Metarock Group Limited's (ASX:MYE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Metarock Group's stock has declined, but its ROE is high at 29%, above the industry average of 10%. Despite this, the company's net income has shrunk by 50% in the past five years, indicating potentia...
By Yahoo! Finance | 1 month ago -
Man accused of killing fellow Leduc high school student wanted tarot cards back, court hears | Globalnews.ca
A man on trial for stabbing a student to death in their high school over tarot cards. The victim, Jennifer Winkler, was killed in front of peers. The accused, Dylan Pountney, wanted his mother's tarot...
By Global News | 2 months ago